Moonshot - topic 423 - an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91021C00043
- Awardee
-
Pistevo Decision LLC UEI E85KNHMS6GM1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $453,123
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Solicitation · Posted Jul 28, 2020
- Contract value 100% obligated
- $453,123.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Herndon, VA 20170, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $54,568 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Original award | $398,555 |
About this award
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $453,123 Small Business Innovation Research (SBIR) Phase I contract to Pistevo Decision LLC, a minority-owned small business, to develop an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients. This Phase I contract is part of a two-year $2 million SBIR Phase II award granted to Pistevo in September 2023. Pistevo is also an approved vendor on the General Services Administration's (GSA) Multiple Award Federal Supply Schedule, allowing federal agencies to directly procure Pistevo's IT professional services. This SBIR Phase I contract is set aside for small businesses.
Quick answers
Who was awarded contract 75N91021C00043?
75N91021C00043 was awarded to Pistevo Decision LLC by National Cancer Institute (National Institutes of Health) on September 16, 2021.
How much is contract 75N91021C00043 worth?
The government has obligated $453,123 on 75N91021C00043.
Was contract 75N91021C00043 competed?
The extent of competition for 75N91021C00043 was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award